| TRADING CENTER |
| Life Technologies to Present at the 28th Annual J.P. Morgan Healthcare Conference - Business Wire | |
| Life Technologies' SOLiD System Finds Mutations in Small Cell Lung Cancer Line - Business Wire | |
| Life Technologies Completes Acquisition of BioTrove - Business Wire | |
| GenVault Announces Supply Agreement With Life Technologies - PR Newswire | |
| Applied Biosystems Debuts Industry's First Acoustic Flow Cytometer - Business Wire | |
| InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc. - GlobeNewswire | |
Road to becoming Amgen CEO - CNNMoney.com | |
Managing Amgen in a recession - CNNMoney.com | |
Amgen on health care reform - CNNMoney.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.42 | 0.07 / 0.12% | 10.98 |
| GILD | Gilead Sciences Inc | 43.00 | -0.01 / -0.02% | 16.60 |
| CELG | Celgene Corporation | 56.38 | -0.42 / -0.74% | 67.93 |
| 2008 Revenue: | $1.6 B | Headquarters: Carlsbad, CA |
| Employees: | 1,200 | CEO: Gregory T. Lucier |
| Net Income: | $31.3 M | Industry: Biotechnology |
| Market Cap: | $9.2 B | Website: www.invitrogen.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| LIFE | 52.17 | +0.35 / +0.68% | 51.82 | 52.18 | 51.67 | Profile Chart News |